Latest KFF Health News Stories
KHN Investigation On Opioid Prescribers Pains Some Readers And Tweeters
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
Common Medications Can Masquerade As Dementia In Seniors
A wide variety of medications used to treat allergies, insomnia, leaky bladders, diarrhea, dizziness, motion sickness, asthma, Parkinson’s disease, chronic obstructive pulmonary disease and psychiatric disorders can interfere with cognition in older patients.
A ‘No-Brainer’? Calls Grow For Medicare To Cover Anti-Rejection Drugs After Kidney Transplant
Banking on new cost estimates, a bipartisan coalition in Congress is poised to try — once again — to end a three-year limit on coverage for lifesaving medication required to keep the organs functioning.
Costos adicionales bloquean el tratamiento para prevenir el VIH
Aunque muchas aseguradoras cubren PrEP, los costos por las pruebas adicionales que hay que realizarse pueden bloquear el acceso a esta terapia preventiva.
Even When HIV Prevention Drug Is Covered, Other Costs Block Treatment
The U.S. Preventive Services Task Force recommended that people who are at high risk of contracting HIV take PrEP, a preventive treatment. The decision means most health plans will be required to cover the drugs without charging patients. But the recommendation doesn’t apply to the other clinical and lab services people need.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
Watch: High Cost Of Insulin Sends Americans To Canada To Stock Up
KHN, in collaboration with PBS NewsHour, reports on the skyrocketing cost of insulin — and the trend’s deadly consequences. The price in the U.S. nearly doubled from 2012 to 2016, prompting some patients and activists to travel to Canada, where insulin can be 90% cheaper.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
Pelosi Aims For Feds To Negotiate Drug Prices, Even For Private Insurers
A draft plan spearheaded by House Speaker Nancy Pelosi would allow the federal government for the first time to negotiate prices for 250 drugs for Medicare and apply those prices to all payers, including employers and insurers.
Trump Has Blessed States’ Exploration Of Importing Drugs. Will It Catch On?
Colorado, Florida and Vermont — with the support of President Donald Trump — are exploring plans to bring drugs across the border from Canada to help lower costs.
How Black Pharmacists Are Closing The Cultural Gap In Health Care
Independent black-owned pharmacies fill a void for African American patients looking for care that’s sensitive to their heritage, beliefs and values.
‘An Arm And A Leg’: Why Are Drug Prices So Random? Meet Mr. PBM
Beware at the pharmacy counter: Your insurance company could be in cahoots with a pharmacy benefit manager — and the negotiations that go on between them are trade secrets.
Middlemen Who Save $$ On Medicines — But Maybe Not For You
Guess who’s back grabbing headlines? Pharmacy benefit managers — those companies that serve as middlemen in the prescription drug pipeline.
Julie Rovner, the chief Washington correspondent for Kaiser Health News, joins Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and Alan Weil of Health Affairs at the Aspen Ideas: Health festival to discuss how consumers’ values impact the politics surrounding the national debate on health care.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
Surgeons’ Opioid-Prescribing Habits Are Hard To Kick
A new data analysis by KHN and Johns Hopkins researchers shows that even as the CDC issued warnings, surgeons handed out many times the number of opioid pills needed for post-op pain.
FDA Overlooked Red Flags In Drugmaker’s Testing of New Depression Medicine
In March, a chemical cousin of the anesthetic and club drug ketamine was approved for the treatment of patients with intractable depression. But critics say studies presented to the FDA provided at best modest evidence it worked and did not include information about the safety of the drug, Spravato, for long-term use.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
